Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance

[1]  Gina M. Butrico,et al.  Glucagon stimulates gluconeogenesis by InsP3R-I mediated hepatic lipolysis , 2020, Nature.

[2]  E. Lander,et al.  Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data. , 2019, Cell reports.

[3]  Tan Zhang,et al.  Adeno-Associated Virus-Mediated Knockdown of SLC16A11 Improves Glucose Tolerance and Hepatic Insulin Signaling in High Fat Diet-Fed Mice. , 2019, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  J. Florez,et al.  The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. , 2019, European journal of endocrinology.

[5]  N. Schneiderman,et al.  Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) , 2019, Scientific Reports.

[6]  G. Shulman,et al.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. , 2019, Annual review of pharmacology and toxicology.

[7]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[8]  J. Lykkesfeldt,et al.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease , 2018, Cellular and Molecular Life Sciences.

[9]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[10]  Mark S. Schmidt,et al.  Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice. , 2018, Cell metabolism.

[11]  A. Morris,et al.  Progress in defining the genetic contribution to type 2 diabetes susceptibility. , 2018, Current opinion in genetics & development.

[12]  K. Petersen,et al.  Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice , 2017, Proceedings of the National Academy of Sciences.

[13]  M. Cruz,et al.  Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric‐onset type 2 diabetes and related glycemic traits in families: A case‐control and case‐parent trio study , 2017, Pediatric diabetes.

[14]  Q. Qian,et al.  Lactic Acid: No Longer an Inert and End-Product of Glycolysis. , 2017, Physiology.

[15]  C. Sempoux,et al.  AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice , 2017, Molecular metabolism.

[16]  M. Bauer,et al.  Retinol saturase coordinates liver metabolism by regulating ChREBP activity , 2017, Nature Communications.

[17]  G. Shulman,et al.  The human longevity gene homolog INDY and interleukin‐6 interact in hepatic lipid metabolism , 2017, Hepatology.

[18]  Nicholette D. Palmer,et al.  Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms , 2017, Cell.

[19]  Michael J. Marcel,et al.  Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. , 2016, The Journal of clinical investigation.

[20]  Pierre Sonveaux,et al.  Monocarboxylate transporters in the brain and in cancer☆ , 2016, Biochimica et biophysica acta.

[21]  Jianguo Xia,et al.  Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis , 2016, Current protocols in bioinformatics.

[22]  L. Ferrucci,et al.  Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice. , 2016, Cell metabolism.

[23]  M. Hanefeld,et al.  Determinants of mortality in patients with type 2 diabetes: a review , 2016, Reviews in Endocrine and Metabolic Disorders.

[24]  C. Bogardus,et al.  Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression , 2015, Diabetes.

[25]  M. G. Ortiz-López,et al.  Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes. , 2015, Gene.

[26]  C. Aguilar-Salinas,et al.  Genetic Determinants for Gestational Diabetes Mellitus and Related Metabolic Traits in Mexican Women , 2015, PloS one.

[27]  G. Shulman,et al.  Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats , 2015, Science.

[28]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[29]  G. Shulman,et al.  Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids , 2015, Proceedings of the National Academy of Sciences.

[30]  Matthias Blüher,et al.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. , 2014, Cell metabolism.

[31]  G. Shulman.  Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. , 2014, The New England journal of medicine.

[32]  Gerald M. Saidel,et al.  Relating tissue/organ energy expenditure to metabolic fluxes in mouse and human: experimental data integrated with mathematical modeling , 2014, Physiological reports.

[33]  G. Shulman,et al.  The Mammalian INDY Homolog Is Induced by CREB in a Rat Model of Type 2 Diabetes , 2014, Diabetes.

[34]  G. Shulman,et al.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes , 2014, Hepatology.

[35]  Tanya M. Teslovich,et al.  Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico , 2013, Nature.

[36]  P. Magistretti,et al.  Resistance to Diet-Induced Obesity and Associated Metabolic Perturbations in Haploinsufficient Monocarboxylate Transporter 1 Mice , 2013, PloS one.

[37]  G. Shulman,et al.  Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. , 2013, Cell metabolism.

[38]  A. Halestrap.  The SLC16 gene family - structure, role and regulation in health and disease. , 2013, Molecular aspects of medicine.

[39]  G. Rutter,et al.  Overexpression of Monocarboxylate Transporter-1 (Slc16a1) in Mouse Pancreatic β-Cells Leads to Relative Hyperinsulinism During Exercise , 2012, Diabetes.

[40]  K. Petersen,et al.  Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance , 2011, Hepatology.

[41]  R. de Cabo,et al.  Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. , 2011, Cell metabolism.

[42]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[43]  B. Astor,et al.  Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study , 2010, International journal of epidemiology.

[44]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[45]  Peter J. Woolf,et al.  GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.

[46]  Oliver Fiehn,et al.  Quality control for plant metabolomics: reporting MSI-compliant studies. , 2008, The Plant journal : for cell and molecular biology.

[47]  K. Motojima,et al.  PPARα Agonists Positively and Negatively Regulate the Expression of Several Nutrient/Drug Transporters in Mouse Small Intestine , 2007 .

[48]  J. Kere,et al.  Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. , 2007, American journal of human genetics.

[49]  Martin F. Fromm,et al.  The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3 , 2007, Drug Metabolism and Disposition.

[50]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[51]  G. Shulman,et al.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.

[52]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[53]  N. Price,et al.  Structure and regulation of acetyl-CoA carboxylase genes of metazoa. , 2005, Biochimica et biophysica acta.

[54]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[55]  D. Meredith,et al.  The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond , 2004, Pflügers Archiv.

[56]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[58]  G. Shulman,et al.  Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. , 2001, American journal of physiology. Endocrinology and metabolism.

[59]  N. Price,et al.  The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.

[60]  A. Bröer,et al.  Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. , 1998, The Biochemical journal.

[61]  C. Cobelli,et al.  Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. , 1996, The Journal of clinical investigation.

[62]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[63]  Todd A. Johnson,et al.  Genome-wide association study identifies three novel loci for type 2 diabetes. , 2014, Human molecular genetics.

[64]  J. Kere,et al.  Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. , 2003, Diabetes.

[65]  S. Wakil,et al.  Fatty acid synthesis and its regulation. , 1983, Annual review of biochemistry.